LU68264A1 - - Google Patents

Info

Publication number
LU68264A1
LU68264A1 LU68264A LU68264DA LU68264A1 LU 68264 A1 LU68264 A1 LU 68264A1 LU 68264 A LU68264 A LU 68264A LU 68264D A LU68264D A LU 68264DA LU 68264 A1 LU68264 A1 LU 68264A1
Authority
LU
Luxembourg
Application number
LU68264A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU68264A1 publication Critical patent/LU68264A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU68264A 1973-07-06 1973-08-20 LU68264A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324875A FR2244520B1 (cg-RX-API-DMAC7.html) 1973-07-06 1973-07-06

Publications (1)

Publication Number Publication Date
LU68264A1 true LU68264A1 (cg-RX-API-DMAC7.html) 1973-10-24

Family

ID=9122192

Family Applications (1)

Application Number Title Priority Date Filing Date
LU68264A LU68264A1 (cg-RX-API-DMAC7.html) 1973-07-06 1973-08-20

Country Status (11)

Country Link
US (1) US3968214A (cg-RX-API-DMAC7.html)
JP (1) JPS5025576A (cg-RX-API-DMAC7.html)
BE (1) BE803804A (cg-RX-API-DMAC7.html)
CH (1) CH581120A5 (cg-RX-API-DMAC7.html)
DE (1) DE2342881A1 (cg-RX-API-DMAC7.html)
ES (1) ES418114A1 (cg-RX-API-DMAC7.html)
FR (1) FR2244520B1 (cg-RX-API-DMAC7.html)
GB (1) GB1450211A (cg-RX-API-DMAC7.html)
LU (1) LU68264A1 (cg-RX-API-DMAC7.html)
NL (1) NL7312324A (cg-RX-API-DMAC7.html)
NO (1) NO137387C (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
US4560402A (en) * 1979-08-15 1985-12-24 Ciba Geigy Corporation 2,4-Diamo-5-(alkylsulfinyl) or alkylsulphonyl)-6-halopyrimidines
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
US5002949A (en) * 1990-05-01 1991-03-26 American Home Products Corporation 5-substituted-6-aminopyrimidine derivatives
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
RU2354648C2 (ru) * 2002-07-19 2009-05-10 Мемори Фармасьютиклз Корпорейшн Соединения 6-амино-1н-индазола и 4-аминобензофурана в качестве ингибиторов фосфодиэстеразы 4
AU2003288994A1 (en) 2002-12-10 2004-06-30 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compounds and medicinal use thereof
AU2006257863A1 (en) * 2005-06-10 2006-12-21 F. Hoffmann-La Roche Ag Trisubstituted amines as phosphodiesterase 4 inhibitors
EP2054392A2 (en) 2006-06-15 2009-05-06 Boehringer Ingelheim International GmbH 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
CA2655315A1 (en) 2006-06-15 2007-12-21 Boehringer Ingelheim International Gmbh 2-anilino-4-aminoalkyleneaminopyrimidines
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817998A (en) * 1971-10-28 1974-06-18 Sandoz Ag 2-amino and substituted amino-4, 6-diamino-5-pyrimidinesulfonamides

Also Published As

Publication number Publication date
GB1450211A (en) 1976-09-22
FR2244520A1 (cg-RX-API-DMAC7.html) 1975-04-18
BE803804A (fr) 1974-02-20
CH581120A5 (cg-RX-API-DMAC7.html) 1976-10-29
DE2342881A1 (de) 1975-01-30
ES418114A1 (es) 1976-03-16
US3968214A (en) 1976-07-06
NL7312324A (nl) 1975-01-08
NO326173L (cg-RX-API-DMAC7.html) 1975-02-03
NO137387B (no) 1977-11-14
FR2244520B1 (cg-RX-API-DMAC7.html) 1977-02-04
NO137387C (no) 1978-02-22
JPS5025576A (cg-RX-API-DMAC7.html) 1975-03-18

Similar Documents

Publication Publication Date Title
AR201231Q (cg-RX-API-DMAC7.html)
FR2244520B1 (cg-RX-API-DMAC7.html)
AR201229Q (cg-RX-API-DMAC7.html)
AU476696B2 (cg-RX-API-DMAC7.html)
AR199451A1 (cg-RX-API-DMAC7.html)
AU477823B2 (cg-RX-API-DMAC7.html)
AR196382A1 (cg-RX-API-DMAC7.html)
AR197627A1 (cg-RX-API-DMAC7.html)
AR200885A1 (cg-RX-API-DMAC7.html)
AU477824B2 (cg-RX-API-DMAC7.html)
AR200256A1 (cg-RX-API-DMAC7.html)
AR193950A1 (cg-RX-API-DMAC7.html)
AR195311A1 (cg-RX-API-DMAC7.html)
AR195948A1 (cg-RX-API-DMAC7.html)
AR196212Q (cg-RX-API-DMAC7.html)
AR196123Q (cg-RX-API-DMAC7.html)
CH566255A5 (cg-RX-API-DMAC7.html)
AU479422A (cg-RX-API-DMAC7.html)
BG23343A1 (cg-RX-API-DMAC7.html)
CH563009A5 (cg-RX-API-DMAC7.html)
BG20153A1 (cg-RX-API-DMAC7.html)
BG20032A1 (cg-RX-API-DMAC7.html)
BG19986A1 (cg-RX-API-DMAC7.html)
CH563205A5 (cg-RX-API-DMAC7.html)
BG18998A1 (cg-RX-API-DMAC7.html)